Evidence map›Paper›PMID 24591004›Full record

ArticleAngewandte Chemie (International ed. in English)2014

A multifaceted secondary structure mimic based on piperidine-piperidinones.

Dongyue Xin, Lisa M Perez, Thomas R Ioerger, Kevin Burgess

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Probing Protein Surfaces: QSAR Analysis with Helix Mimetics.Chembiochem : a European journal of chemical biology · 2016
    Article
  7. Review
  8. Article
  9. Orthogonal functionalisation of α-helix mimetics.Organic & biomolecular chemistry · 2014
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dongyue XinDepartment of Chemistry, Texas A & M University, Box 30012, College Station, TX 77841-3012 (USA).
Lisa M Perez
Thomas R Ioerger
Kevin Burgess

Funding

Development of an Optimized System for Non-covalent Delivery of Proteins into CelR01GM087981 · NIGMS · TEXAS A&M UNIVERSITY · PI BURGESS, KEVIN · 2009 to 2012
$1.3M
NIGMS NIH HHS GM087981NIGMS NIH HHS R01 GM087981
6 · The paper itself

Abstract

Minimalist secondary structure mimics are typically made to resemble one interface in a protein-protein interaction (PPI), and thus perturb it. We recently proposed suitable chemotypes can be matched with interface regions directly, without regard for secondary structures. Here we describe a modular synthesis of a new chemotype 1, simulation of its solution-state conformational ensemble, and correlation of that with ideal secondary structures and real interface regions in PPIs. Scaffold 1 presents amino acid side-chains that are quite separated from each other, in orientations that closely resemble ideal sheet or helical structures, similar non-ideal structures at PPI interfaces, and regions of other PPI interfaces where the mimic conformation does not resemble any secondary structure. 68 different PPIs where conformations of 1 matched well were identified. A new method is also presented to determine the relevance of a minimalist mimic crystal structure to its solution conformations. Thus DLD-1 faf crystallized in a conformation that is estimated to be 0.91 kcal mol(-1) above the minimum energy solution state.

Indexed as

Amino AcidsModels, MolecularMolecular ConformationPiperidinesProtein BindingProtein Structure, SecondaryAmino AcidspiperidinePiperidinesamino acidscomputational chemistryhelical structurespeptidomimeticsprotein-protein interactionssecondary structures

Identifiers

PMID24591004
PMCPMC4019009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.